These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 19533135)

  • 1. Intestinal macrophages: differentiation and involvement in intestinal immunopathologies.
    Weber B; Saurer L; Mueller C
    Semin Immunopathol; 2009 Jul; 31(2):171-84. PubMed ID: 19533135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptations of intestinal macrophages to an antigen-rich environment.
    Schenk M; Mueller C
    Semin Immunol; 2007 Apr; 19(2):84-93. PubMed ID: 17055292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the macrophage in sentinel responses in intestinal immunity.
    Sheikh SZ; Plevy SE
    Curr Opin Gastroenterol; 2010 Nov; 26(6):578-82. PubMed ID: 20717022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal macrophages and response to microbial encroachment.
    Smith PD; Smythies LE; Shen R; Greenwell-Wild T; Gliozzi M; Wahl SM
    Mucosal Immunol; 2011 Jan; 4(1):31-42. PubMed ID: 20962772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities.
    Smith PD; Smythies LE; Mosteller-Barnum M; Sibley DA; Russell MW; Merger M; Sellers MT; Orenstein JM; Shimada T; Graham MF; Kubagawa H
    J Immunol; 2001 Sep; 167(5):2651-6. PubMed ID: 11509607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation.
    Uo M; Hisamatsu T; Miyoshi J; Kaito D; Yoneno K; Kitazume MT; Mori M; Sugita A; Koganei K; Matsuoka K; Kanai T; Hibi T
    Gut; 2013 Dec; 62(12):1734-44. PubMed ID: 23013725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity.
    Smythies LE; Sellers M; Clements RH; Mosteller-Barnum M; Meng G; Benjamin WH; Orenstein JM; Smith PD
    J Clin Invest; 2005 Jan; 115(1):66-75. PubMed ID: 15630445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells.
    Rugtveit J; Haraldsen G; Høgåsen AK; Bakka A; Brandtzaeg P; Scott H
    Gut; 1995 Sep; 37(3):367-73. PubMed ID: 7590432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa--implications for pathogenesis.
    Grimm MC; Pavli P; Van de Pol E; Doe WF
    Clin Exp Immunol; 1995 May; 100(2):291-7. PubMed ID: 7538056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbations of mucosal homeostasis through interactions of intestinal microbes with myeloid cells.
    Schey R; Danzer C; Mattner J
    Immunobiology; 2015 Feb; 220(2):227-35. PubMed ID: 25466587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense.
    Farache J; Zigmond E; Shakhar G; Jung S
    Immunol Cell Biol; 2013 Mar; 91(3):232-9. PubMed ID: 23399695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell co-stimulatory molecules are upregulated on intestinal macrophages from inflammatory bowel disease mucosa.
    Rogler G; Hausmann M; Spöttl T; Vogl D; Aschenbrenner E; Andus T; Falk W; Schölmerich J; Gross V
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1105-11. PubMed ID: 10524639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier.
    Neal MD; Leaphart C; Levy R; Prince J; Billiar TR; Watkins S; Li J; Cetin S; Ford H; Schreiber A; Hackam DJ
    J Immunol; 2006 Mar; 176(5):3070-9. PubMed ID: 16493066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The monocyte-macrophage axis in the intestine.
    Bain CC; Mowat AM
    Cell Immunol; 2014; 291(1-2):41-8. PubMed ID: 24726741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD).
    Rugtveit J; Bakka A; Brandtzaeg P
    Clin Exp Immunol; 1997 Oct; 110(1):104-13. PubMed ID: 9353156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal Macrophages in Resolving Inflammation.
    Hine AM; Loke P
    J Immunol; 2019 Aug; 203(3):593-599. PubMed ID: 31332080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD14(+) macrophages that accumulate in the colon of African AIDS patients express pro-inflammatory cytokines and are responsive to lipopolysaccharide.
    Cassol E; Rossouw T; Malfeld S; Mahasha P; Slavik T; Seebregts C; Bond R; du Plessis J; Janssen C; Roskams T; Nevens F; Alfano M; Poli G; van der Merwe SW
    BMC Infect Dis; 2015 Oct; 15():430. PubMed ID: 26475133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal macrophages: unique effector cells of the innate immune system.
    Smith PD; Ochsenbauer-Jambor C; Smythies LE
    Immunol Rev; 2005 Aug; 206():149-59. PubMed ID: 16048547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of macrophages in inflammatory bowel diseases.
    Heinsbroek SE; Gordon S
    Expert Rev Mol Med; 2009 May; 11():e14. PubMed ID: 19439108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.